Heart failure in infants and children

Pediatrics in Review

Volumn 31, Issue 1, 2010, Pages 4-12

  Madriago, Erin ^a   Silberbach, Michael ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CATECHOLAMINE; CYTOKINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GROWTH HORMONE; INTERLEUKIN 6; LOOP DIURETIC AGENT; LOSARTAN; MILRINONE; MINERALOCORTICOID; NESIRITIDE; NITRATE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE IV INHIBITOR; PLACEBO; SOMATOMEDIN; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR AGENT;

ADRENERGIC SYSTEM; ANEMIA; AORTA COARCTATION; AORTA SUBVALVULAR STENOSIS; AORTA SUPRAVALVULAR STENOSIS; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; AORTOPULMONARY SEPTAL DEFECT; ARTERIOVENOUS FISTULA; BRADYCARDIA; CACHEXIA; CARDIOMYOPATHY; CHILDHOOD DISEASE; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; COR TRIATRIATUM; DIABETIC KETOACIDOSIS; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; EVIDENCE BASED MEDICINE; FLUID RETENTION; HEART AFTERLOAD; HEART ARRHYTHMIA; HEART ATRIUM SEPTUM DEFECT; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART PRELOAD; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART VENTRICLE SEPTUM DEFECT; HEART WORK; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOTENSION; HYPOTHYROIDISM; INFLAMMATION; KIDNEY FAILURE; METABOLISM; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; MUSCULAR DYSTROPHY; MYOCARDITIS; NEUROENDOCRINE SYSTEM; PATENT DUCTUS ARTERIOSUS; PEDIATRIC ADVANCED LIFE SUPPORT; PEDIATRIC SURGERY; PULMONARY VEIN OBSTRUCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; SYSTEMIC VASCULAR RESISTANCE; TACHYCARDIA;

ABNORMALITIES, MULTIPLE; CARDIOMYOPATHIES; HEART DEFECTS, CONGENITAL; HEART FAILURE; HUMANS; INFANT; MYOCARDIAL CONTRACTION;

EID: 76149127026     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.31-1-4     Document Type: Review

References (21)

1. Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Hertz MI. Registry for the International Society for Heart and Lung Transplantation: seventh official pediatric report-2004. J Heart Lung Transplant. 2004;23:933-947
2. Kay JD, Colan SD, Graham TP Jr. Congestive heart failure in pediatric patients. Am Heart J. 2001;142:923-928
3. Lipshultz SE. Ventricular dysfunction clinical research in infants, children and adolescents. Prog Pediatr Cardiol. 2000;12:1-28
4. Anker SD, Steinborn W, Strassburg S. Cardiac cachexia. Ann Med. 2004;36:518-529
5. von Haehling S, Doehner W, Anker SD. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res. 2007;73:298-309
6. Colao A. The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin Endocrinol (Oxf). 2008;69:347-358
7. Silberbach M, Roberts CT Jr. Natriuretic peptide signalling: molecular and cellular pathways to growth regulation. Cellular Signalling. 2001;13:221-231
8. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348:1647-1655
9. Satou GM, Lacro RV, Chung T, Gauvreau K, Jenkins KJ. Heart size on chest x-ray as a predictor of cardiac enlargement by echocardiography in children. Pediatr Cardiol. 2001;22:218-222
10. Law YM, Hoyer AW, Reller MD, Silberbach M. Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! study. J Am Coll Cardiol. 2009;54:1467-1475.
11. Kaneko K, Kanda T, Yamauchi Y, et al. C-reactive protein in dilated cardiomyopathy. Cardiology. 1999;91:215-219
12. Ratnasamy C, Kinnamon DD, Lipshultz SE, Rusconi P. Associations between neurohormonal and inflammatory activation and heart failure in children. Am Heart J. 2008;155:527-533
13. Shaddy RE, Boucek MM, Hsu DT, et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007;298:1171-1179
14. Canter CE, Shaddy RE, Bernstein D, et al. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;115:658-676
15. Ross RD, Bollinger RO, Pinsky WW. Grading the severity of congestive heart failure in infants. Pediatr Cardiol. 1992;13:72-75
16. Connolly D, Rutkowski M, Auslender M, Artman M. The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children. J Pediatr. 2001;138:644-648
17. Rosenthal D, Chrisant MR, Edens E, et al. International Society for Heart and Lung Transplantation: practice guidelines for management of heart failure in children. J Heart Lung Transplant. 2004;23:1313-1333
18. Colao A, Terzolo M, Bondanelli M, et al. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment. Clin Endocrinol (Oxf). 2008;69:613-620
19. Lainscak M, von Haehling S, Springer J, Anker SD. Biomarkers for chronic heart failure. Heart Fail Monit. 2007;5:77-82
20. Akashi YJ, Springer J, Anker SD. Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches. Curr Heart Fail Rep. 2005;2:198-203
21. Moffett BS, Chang AC. Future pharmacologic agents for treatment of heart failure in children. Pediatr Cardiol. 2006;27:533-551